CPG
TRAW icon

Cornerstone Planning Group’s Traws Pharma TRAW Stock Holding History

Cornerstone Planning Group’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$1 – 1710
2025
Q1 		$1 Hold
1
– – ﹤0.01% 1551
2024
Q4 		$7 Hold
1
– – ﹤0.01% 1390
2024
Q3 		$5 Hold
1
– – ﹤0.01% 1291
2024
Q2 		$12 Hold
1
– – ﹤0.01% 1239
2024
Q1 		$21 Hold
1
– – ﹤0.01% 1078
2023
Q4 		$25 Hold
1
– – ﹤0.01% 937
2023
Q3 		$23 Hold
1
– – ﹤0.01% 1173
2023
Q2 		$39 Buy
+1
New +$27 ﹤0.01% 1555
2022
Q4 		$29 Buy
+1
New +$19 ﹤0.01% 1556

Other funds holding TRAW

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cornerstone Planning Group's TRAW Position: Q2 2025 in Review

Cornerstone Planning Group sold out of Traws Pharma (TRAW) in Q2 2025, closing a stake of 1 share — an estimated $1 sold.

Cornerstone Planning Group first reported a position in TRAW in Q4 2022 and held it in 9 quarters. The position peaked at $39 in Q2 2023. 19 funds tracked by Wall St. Rank hold TRAW as of Q2 2025.

  • Cornerstone Planning Group reported no remaining Traws Pharma position as of Q2 2025 after selling out during the quarter.
  • Cornerstone Planning Group sold 1 Traws Pharma share in Q2 2025, an estimated $1.
  • Cornerstone Planning Group first reported a position in Traws Pharma in Q4 2022 and held it in 9 quarters.
  • Cornerstone Planning Group's Traws Pharma position peaked at $39 in Q2 2023.
  • 19 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2025.

Based on Cornerstone Planning Group's 13F filing for Q2 2025, filed 11 Aug 2025.